vs
Esperion Therapeutics, Inc.（ESPR）与WSFS FINANCIAL CORP（WSFS）财务数据对比。点击上方公司名可切换其他公司
WSFS FINANCIAL CORP的季度营收约是Esperion Therapeutics, Inc.的1.6倍（$275.3M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 7.5%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 1.7%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
WSFS金融集团是一家金融服务企业，核心子公司WSFS银行是总部位于特拉华州及大特拉华谷地区规模最大、经营历史最久的本地管理银行与财富管理机构。集团共运营115个网点，其中88个为银行网点，分布在宾夕法尼亚、特拉华、新泽西、佛罗里达、弗吉尼亚、内华达六州，提供全面金融服务。
ESPR vs WSFS — 直观对比
营收规模更大
WSFS
是对方的1.6倍
$168.4M
营收增速更快
ESPR
高出136.2%
7.5%
两年增速更快
ESPR
近两年复合增速
1.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $275.3M |
| 净利润 | — | $86.8M |
| 毛利率 | — | — |
| 营业利润率 | 50.6% | — |
| 净利率 | — | 31.5% |
| 营收同比 | 143.7% | 7.5% |
| 净利润同比 | — | 31.7% |
| 每股收益（稀释后） | $0.32 | $1.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRWSFS
| Q1 26 | — | $275.3M | ||
| Q4 25 | $168.4M | $271.9M | ||
| Q3 25 | $87.3M | $270.5M | ||
| Q2 25 | $82.4M | $267.5M | ||
| Q1 25 | $65.0M | $256.1M | ||
| Q4 24 | $69.1M | $261.5M | ||
| Q3 24 | $51.6M | $267.7M | ||
| Q2 24 | $73.8M | $266.0M |
净利润ESPRWSFS
| Q1 26 | — | $86.8M | ||
| Q4 25 | — | $72.7M | ||
| Q3 25 | $-31.3M | $76.4M | ||
| Q2 25 | $-12.7M | $72.3M | ||
| Q1 25 | $-40.5M | $65.9M | ||
| Q4 24 | — | $64.2M | ||
| Q3 24 | $-29.5M | $64.4M | ||
| Q2 24 | $-61.9M | $69.3M |
营业利润率ESPRWSFS
| Q1 26 | — | — | ||
| Q4 25 | 50.6% | 35.8% | ||
| Q3 25 | -11.4% | 37.3% | ||
| Q2 25 | 8.6% | 35.7% | ||
| Q1 25 | -34.0% | 34.0% | ||
| Q4 24 | -6.4% | 32.3% | ||
| Q3 24 | -31.0% | 31.9% | ||
| Q2 24 | 3.5% | 34.0% |
净利率ESPRWSFS
| Q1 26 | — | 31.5% | ||
| Q4 25 | — | 26.7% | ||
| Q3 25 | -35.9% | 28.3% | ||
| Q2 25 | -15.4% | 27.0% | ||
| Q1 25 | -62.2% | 25.7% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | -57.2% | 24.1% | ||
| Q2 24 | -83.9% | 26.0% |
每股收益（稀释后）ESPRWSFS
| Q1 26 | — | $1.64 | ||
| Q4 25 | $0.32 | $1.33 | ||
| Q3 25 | $-0.16 | $1.37 | ||
| Q2 25 | $-0.06 | $1.27 | ||
| Q1 25 | $-0.21 | $1.12 | ||
| Q4 24 | $-0.14 | $1.08 | ||
| Q3 24 | $-0.15 | $1.08 | ||
| Q2 24 | $-0.33 | $1.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $2.7B |
| 总资产 | $465.9M | $22.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRWSFS
| Q1 26 | — | — | ||
| Q4 25 | $167.9M | $1.7B | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $86.1M | — | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | $1.2B | ||
| Q3 24 | $144.7M | — | ||
| Q2 24 | $189.3M | — |
股东权益ESPRWSFS
| Q1 26 | — | $2.7B | ||
| Q4 25 | $-302.0M | $2.7B | ||
| Q3 25 | $-451.4M | $2.8B | ||
| Q2 25 | $-433.5M | $2.7B | ||
| Q1 25 | $-426.2M | $2.7B | ||
| Q4 24 | $-388.7M | $2.6B | ||
| Q3 24 | $-370.2M | $2.7B | ||
| Q2 24 | $-344.2M | $2.5B |
总资产ESPRWSFS
| Q1 26 | — | $22.1B | ||
| Q4 25 | $465.9M | $21.3B | ||
| Q3 25 | $364.0M | $20.8B | ||
| Q2 25 | $347.1M | $20.8B | ||
| Q1 25 | $324.0M | $20.5B | ||
| Q4 24 | $343.8M | $20.8B | ||
| Q3 24 | $314.1M | $20.9B | ||
| Q2 24 | $352.3M | $20.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESPRWSFS
| Q1 26 | — | — | ||
| Q4 25 | $45.2M | $220.0M | ||
| Q3 25 | $-4.3M | $121.5M | ||
| Q2 25 | $-31.4M | $37.2M | ||
| Q1 25 | $-22.6M | $8.7M | ||
| Q4 24 | $-35.0M | $219.9M | ||
| Q3 24 | $-35.3M | $3.1M | ||
| Q2 24 | $-7.2M | $44.8M |
自由现金流ESPRWSFS
| Q1 26 | — | — | ||
| Q4 25 | — | $213.6M | ||
| Q3 25 | — | $120.3M | ||
| Q2 25 | — | $35.2M | ||
| Q1 25 | — | $6.3M | ||
| Q4 24 | — | $205.6M | ||
| Q3 24 | $-35.5M | $-489.0K | ||
| Q2 24 | $-7.3M | $42.1M |
自由现金流率ESPRWSFS
| Q1 26 | — | — | ||
| Q4 25 | — | 78.6% | ||
| Q3 25 | — | 44.5% | ||
| Q2 25 | — | 13.2% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 78.6% | ||
| Q3 24 | -68.7% | -0.2% | ||
| Q2 24 | -9.9% | 15.8% |
资本支出强度ESPRWSFS
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 2.3% | ||
| Q3 25 | 0.0% | 0.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.0% | 0.9% | ||
| Q4 24 | 0.0% | 5.5% | ||
| Q3 24 | 0.3% | 1.4% | ||
| Q2 24 | 0.1% | 1.0% |
现金转化率ESPRWSFS
| Q1 26 | — | — | ||
| Q4 25 | — | 3.03× | ||
| Q3 25 | — | 1.59× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 3.43× | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
WSFS
暂无分部数据
